Regulation of p53 by Jagged1 Contributes to Angiotensin II-Induced Impairment of Myocardial Angiogenesis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Guan, Aili ^a,b   Gong, Hui ^a   Ye, Yong ^a   Jia, Jianguo ^a   Zhang, Guoping ^a   Li, Bingyu ^a   Yang, Chunjie ^a   Qian, Sanli ^a   Sun, Aijun ^a   Chen, Ruizhen ^a   Ge, Junbo ^a   Zou, Yunzeng ^a  

^a FUDAN UNIVERSITY   (China)

^b QINGDAO MUNICIPAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; DELTA LIKE 4 PROTEIN; HYPOXIA INDUCIBLE FACTOR; JAGGED1; MATRIGEL; NOTCH RECEPTOR; PIFITHRIN ALPHA; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; GENE SILENCING; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; MYOCARDIAL ANGIOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

ANGIOTENSIN II; ANIMALS; BENZOTHIAZOLES; CALCIUM-BINDING PROTEINS; CELL NUCLEUS; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFUSION PUMPS, IMPLANTABLE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PRIMARY CELL CULTURE; PROTEOGLYCANS; RATS; RATS, WISTAR; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TOLUENE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884887910     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076529     Document Type: Article

References (33)

1. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, et al. (2007) p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 446: 444-448. doi:10.1038/nature05602. PubMed: 17334357.
2. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, et al. (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108-2118. doi:10.1172/JCI24682. PubMed: 16075055.
3. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, et al. (1990) Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest 86: 1913-1920. doi:10.1172/JCI114924. PubMed: 2174912.
4. Masuda T, Muto S, Fujisawa G, Iwazu Y, Kimura M, et al. (2012) Heart angiotensin II-induced cardiomyocyte hypertrophy suppresses coronary angiogenesis and progresses diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 302: H1871-H1883. doi:10.1152/ajpheart.00663.2011. PubMed: 22389386.
5. Belabbas H, Zalvidea S, Casellas D, Molès JP, Galbes O, et al. (2008) Contrasting effect of exercise and angiotensin II hypertension on in vivo and in vitro cardiac angiogenesis in rats. Am J Physiol Regul Integr Comp Physiol 295: R1512-R1518. doi:10.1152/ajpregu.00014.2008. PubMed: 18768771.
6. Zou Y, Li J, Ma H, Jiang H, Yuan J, Gong H, et al. (2011) Heat shock transcription factor 1 protects heart after pressure overload through promoting myocardial angiogenesis in male mice. J Mol Cell Cardiol;51: 821-829. doi:10.1016/j.yjmcc.2011.07.030. PubMed: 21854784.
7. Benedito R, Roca C, Sörensen I, Adams S, Gossler A, et al. (2009) The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137: 1124-1135. doi:10.1016/j.cell.2009.03.025. PubMed: 19524514.
8. Wang XH, Chen SF, Jin HM, Hu RM, (2009) Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats. Life Sci 84: 240-249. doi:10.1016/j.lfs.2008.12.010. PubMed: 19135459.
9. Marelli-Berg FM, Peek E, Lidington EA, Stauss HJ, Lechler RI, (2000) Isolation of endothelial cells from murine tissue. J Immunol Methods 244: 205-215. doi:10.1016/S0022-1759(00)00258-1. PubMed: 11033033.
10. Lin L, Gong H, Ge J, Jiang G, Zhou N, et al. (2011) High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy. Biochem Biophys Res Commun 404: 28-33. doi:10.1016/j.bbrc.2010.11.037. PubMed: 21094634.
11. Liu P, Xu B, Cavalieri TA, Hock CE, (2006) Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats. Shock 26: 608-614. doi:10.1097/01.shk.0000232273.11225.af. PubMed: 17117137.
12. Guan A, Zou Y, Gong H, Niu Y, Ye Y, et al. (2012) AngiotensinII preconditioning promotes angiogenesis in vitro via ERKs phosphorylation. J Biomed Biotechnol, 2012(2012):737134. PubMed: 22500105.
13. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, et al. (1999) A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285: 1733-1737. doi:10.1126/science.285.5434.1733. PubMed: 10481009.
14. Sohn D, Graupner V, Neise D, Essmann F, Schulze-Osthoff K, (2009) Pifithrin-alpha protects against DNA damage-induced apoptosis downstream of mitochondria independent of p53. Cell Death Differ 16: 869-878. doi:10.1038/cdd.2009.17. PubMed: 19229248.
15. Safran M, Kim WY, O'Connell F, Flippin L, Horner JW, et al. (2006) Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci U S A;103: 105-110. doi:10.1073/pnas.0509459103. PubMed: 16373502.
16. Yu X, Zou J, Ye Z, Hammond H, Chen G, Tokunaga A, et al. (2008) Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. Cell Stem Cell 2: 461-471. doi:10.1016/j.stem.2008.03.001. PubMed: 18462696.
17. Gottifredi V, Prives C, Molecular biology (2001) Getting p53 out of the nucleus. Science 292: 1851-1852 doi:10.1126/science.1062238. PubMed: 11397937.
18. Luo Y, Kuo CC, Shen H, Chou J, Greig NH, et al. (2009) Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol 65: 520-530. doi:10.1002/ana.21592. PubMed: 19475672.
19. Le TT, Conley KW, Mead TJ, Rowan S, Yutzey KE, et al. (2012) Requirements for Jag1-Rbpj mediated Notch signaling during early mouse lens development. Dev Dyn 241: 493-504. doi:10.1002/dvdy.23739. PubMed: 22275127.
20. Ainscough JF, Drinkhill MJ, Sedo A, Turner NA, Brooke DA, et al. (2009) Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction. Cardiovasc Res 81: 592-600. PubMed: 18703536.
21. Li L, Zhou N, Gong H, Wu J, Lin L, Komuro I, et al. (2010) Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice. Hypertens Res 33: 1289-1297. doi:10.1038/hr.2010.182. PubMed: 20944638.
22. He Z, Way KJ, Arikawa E, Chou E, Opland DM, Clermont A, et al. (2005) Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium. J Biol Chem 280: 15719-15726. doi:10.1074/jbc.M413493200. PubMed: 15699040.
23. Prives C, Hall PA, (1999) The p53 pathway. J Pathol 187: 112-126. doi:10.1002/(SICI)1096-9896(199901)187:1. PubMed: 10341712.
24. Liang SH, Clarke MF, (2001) Regulation of p53 localization. Eur J Biochem 268: 2779-2783. doi:10.1046/j.1432-1327.2001.02227.x. PubMed: 11358492.
25. Appella E, Anderson CW, (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772. doi:10.1046/j.1432-1327.2001.02225.x. PubMed: 11358490.
26. Giaccia AJ, Kastan MB, (1998) The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12: 2973-2983. doi:10.1101/gad.12.19.2973. PubMed: 9765199.
27. Keller DM, Zeng X, Wang Y, Zhang QH, Shu H, et al. (2001) A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell 7: 283-292. doi:10.1016/S1097-2765(01)00176-9. PubMed: 11239457.
28. Semenza GL, (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578. doi:10.1146/annurev.cellbio.15.1.551. PubMed: 10611972.
29. Pugh CW, Ratcliffe PJ, (2003) The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin Cancer Biol 13: 83-89. doi:10.1016/S1044-579X(02)00103-7. PubMed: 12507560.
30. Rehman AO, Wang CY, (2006) Notch signaling in the regulation of tumor angiogenesis. Trends Cell Biol 16: 293-300. doi:10.1016/j.tcb.2006.04.003. PubMed: 16697642.
31. Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, et al. (2005) Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8: 13-23. doi:10.1016/j.ccr.2005.06.004. PubMed: 16023595.
32. Ilagan MX, Kopan R, (2007) SnapShot: notch signaling pathway. Cell 128: 1246. PubMed: 17382890.
33. Tao L, Roberts AL, Dunphy KA, Bigelow C, Yan H, et al. (2011) Repression of mammary stem/progenitor cells by p53 is mediated by Notch and separable from apoptotic activity. Stem Cells 29: 119-127. doi:10.1002/stem.552. PubMed: 21280161.